The safety of a mucosal vaccine using the C-terminal fragment of Clostridium perfringens enterotoxin.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Pharmazie

• Publication date

  2010-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 21105580
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Claudin 4-targeted protein incorporated into PLGA nanoparticles can mediate M cell targeted delivery.

  2010cited by this paper
• Intranasal delivery to the central nervous system: mechanisms and experimental considerations.

  2010cited by this paper
• A claudin-4 modulator enhances the mucosal absorption of a biologically active peptide.

  2010cited by this paper
• A Novel Tumor-Targeted Therapy Using a Claudin-4-Targeting Molecule

  2009cited by this paper
• Immunological commonalities and distinctions between airway and digestive immunity.

  2008cited by this paper
• Mucosal vaccines: the promise and the challenge

  2006cited by this paper
• Preparation of a Claudin-Targeting Molecule Using a C-Terminal Fragment of Clostridium perfringens Enterotoxin

  2006cited by this paper
• Claudins in occluding junctions of humans and flies.

  2006cited by this paper
• A Novel Strategy for the Enhancement of Drug Absorption Using a Claudin Modulator

  2005cited by this paper
• New insights into the cytotoxic mechanisms of Clostridium perfringens enterotoxin.

  2004cited by this paper
• Size-selective loosening of the blood-brain barrier in claudin-5–deficient mice

  2003cited by this paper
• Endocytosis of epithelial apical junctional proteins by a clathrin-mediated pathway into a unique storage compartment.

  2003cited by this paper
• Characteristics of Claudin Expression in Follicle-Associated Epithelium of Peyer's Patches: Preferential Localization of Claudin-4 at the Apex of the Dome Region

  2003cited by this paper
• Claudin-based tight junctions are crucial for the mammalian epidermal barrier

  2002cited by this paper
• Multifunctional strands in tight junctions

  2001cited by this paper
• Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands.

  1999cited by this paper
• Clostridium perfringens Enterotoxin Fragment Removes Specific Claudins from Tight Junction Strands

  1999cited by this paper
• Molecular Cloning and Functional Characterization of the Receptor for Clostridium perfringens Enterotoxin

  1997cited by this paper

• In-silico design and production of a novel antigenic chimeric Shigella IpaB fused to C-terminal of Clostridium perfringens enterotoxin

  2019influential citation
• Clostridium perfringens enterotoxin-based protein engineering for the vaccine design and delivery system.

  2019cites this paper
• Potential for Tight Junction Protein–Directed Drug Development Using Claudin Binders and Angubindin-1

  2019cites this paper
• Development of Adjuvant-Free Bivalent Food Poisoning Vaccine by Augmenting the Antigenicity of Clostridium perfringens Enterotoxin

  2018cites this paper
• Impaired airway mucociliary function reduces antigen-specific IgA immune response to immunization with a claudin-4-targeting nasal vaccine in mice

  2018cites this paper
• In silico design of a novel chimeric shigella IpaB fused to C terminal of clostridium perfringens enterotoxin as a vaccine candidate

  2017cites this paper
• Distinct presence of the tight junction protein claudin-3 in olfactory bulb and fila olfactoria of the mouse.

  2017cites this paper
• Strategies that Target Tight Junctions for Enhanced Drug Delivery.

  2016cites this paper
• Immunization with recombinant bivalent chimera r-Cpae confers protection against alpha toxin and enterotoxin of Clostridium perfringens type A in murine model.

  2015cites this paper
• C-Terminal Clostridium perfringens Enterotoxin-Mediated Antigen Delivery for Nasal Pneumococcal Vaccine

  2015cites this paper
• M cell-targeting strategy facilitates mucosal immune response and enhances protection against CVB3-induced viral myocarditis elicited by chitosan-DNA vaccine.

  2014cites this paper
• Conception de constructions liposomiques destinées à la vaccination antitumorale par voie respiratoire

  2014cites this paper
• Regulation of Tight Junctions for Therapeutic Advantages

  2013cites this paper
• Tight Junctions in Cancer Metastasis

  2013cites this paper
• Medical Applications of Clostridia and Clostridial Toxins

  2012cites this paper
• Use of Clostridium perfringens Enterotoxin and the Enterotoxin Receptor-Binding Domain (C-CPE) for Cancer Treatment: Opportunities and Challenges

  2011cites this paper